
Brian J DeGuzman MD
Adult Cardiac Surgery
Cheif Medical Officer PAVmed Inc
Join to View Full Profile
10104 E Clinton StScottsdale, AZ 85260
Phone+1 917-703-0212
Fax+1 212-634-7403
Dr. DeGuzman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Cleveland Clinic FoundationFellowship, Thoracic Surgery - Independent, 2000 - 2001
Mass General Brigham/Brigham and Women's Hospital/Children's HospitalFellowship, Thoracic Surgery - Independent, 1998 - 2000
University of ConnecticutResidency, Surgery, 1990 - 1997
Georgetown University School of MedicineClass of 1990
Certifications & Licensure
AZ State Medical License 2006 - 2026
MA State Medical License 2002 - 2011
OH State Medical License 2001 - 2003
Publications & Presentations
PubMed
- Enhancing the Diagnostic Yield of EGD for Diagnosis of Barrett Esophagus Through Methylated DNA Biomarker Triage.Jayde E Kurland, Sheena B Patel, Richard Englehardt, Seper Dezfoli, Daniel M Tseng
Gastroenterology & Hepatology. 2025-04-01 - Real-World Clinical Utility of a Methylated DNA Biomarker Assay on Samples Collected with a Swallowable Capsule-Balloon for Detection of Barrett's Esophagus (BE).Dan Lister, Andy Fine, Shail Maheshwari, Paul S Bradley, Kimberly Lister
Medicina. 2024-12-13 - 2 citationsUse of a Two-Gene Methylated DNA Biomarker Assay and Nonendoscopic Balloon for Detection of Barrett Esophagus Among High-Risk Individuals in a Screening Population.Nicholas J Shaheen, Mohamed O Othman, Jawar Taunk, Kenneth J Chang, Sathya Jaganmohan
The American Journal of Gastroenterology. 2024-11-26
Press Mentions
PAVmed Subsidiary, Veris Health and the Ohio State University Comprehensive Cancer Center Launch Commercial Phase of Strategic Partnership AgreementOctober 7th, 2025
PAVmed Subsidiary, Veris Health, Enters into Strategic Partnership Agreement with the Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research InstituteJune 3rd, 2025
USPTO Grants PAVmed Patent Covering Its CarpX™ DeviceAugust 21st, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









